Ultrasound‐Boosted Liposomal Prodrug Overcomes Age‐Associated Biodistribution Disparity in Pediatric Solid Tumor Therapy
Advanced Science · 2026
DOI: 10.1002/advs.202513148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Danfei Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Zh…. Hauptthemen laut MEDLINE: Prodrugs, Liposomes, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, Science and Technology Foundation of Administration of Traditional Chinese Medicine of Zhejiang Province.
Abstract (Originalsprache)
Clinical adoption of nanodrugs for pediatric cancer is hindered by age‐associated disparities, with unclear mechanisms limiting nanotherapeutics for childhood solid tumors. Here, we originally find that the in vivo biodistribution of nanocarriers shows marked age differences: juvenile tumor‐bearing mice have worse off‐target distribution than adults, due to vigorous neovascular proliferation in normal tissues and heightened macrophage phagocytosis in liver and spleen. To address this challenge, an ultrasound‐activated liposomal prodrug (CSCPTL) is designed to overcome age‐related disparities in off‐target distribution. CSCPTL is composed of a camptothecin‐lipid prodrug conjugate (SCPT) containing the reactive oxygen species (ROS)‐cleavable thioketal linker, a sonosensitizer (chlorin e6, Ce6)‐modified lipid, and other commercially available lipids. Upon intravenous injection, the inactive SCPT exerts minimal pharmacological effects on healthy cells. Conversely, once CSCPTL reaches the tumor site and is internalized by cancer cells, ultrasound irradiation activates Ce6 rapidly to generate massive ROS, which cleaves the thioketal linker to release active camptothecin to induce cell apoptosis. CSCPTL showed potent antitumor efficacy in juvenile hepatoblastoma models, showing superior biocompatibility and no side effects, compared with clinically approved nanodrugs such as Abraxane, Doxil, and Onivyde. This study highlights age‐related off‐target issues and offers a promising ultrasound‐controlled strategy for childhood solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Pharmacy, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
- College of Chemical and Biological Engineering, Zhejiang Key Laboratory of Smart Biomaterials and Key Laboratory of Biomass Chemical Engineering of Ministry of Education, Zhejiang University, Hangzhou, China.
- Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
ORCID-Profile: Zhuxian Zhou
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
- Science and Technology Foundation of Administration of Traditional Chinese Medicine of Zhejiang Province
Zitieren
APA
Chen, D., Xu, J., Chen, J., Hu, J., Xuan, X., Cai, H., Yang, M., Zhou, Z., & Wang, G. (2026). Ultrasound‐Boosted Liposomal Prodrug Overcomes Age‐Associated Biodistribution Disparity in Pediatric Solid Tumor Therapy. Advanced Science. https://doi.org/10.1002/advs.202513148
Vancouver
Chen D, Xu J, Chen J, Hu J, Xuan X, Cai H, et al. Ultrasound‐Boosted Liposomal Prodrug Overcomes Age‐Associated Biodistribution Disparity in Pediatric Solid Tumor Therapy. Advanced Science. 2026. doi:10.1002/advs.202513148
BibTeX
@article{Chen2026,
author = {Chen, Danfei and Xu, Junjun and Chen, Jian and Hu, Jue and Xuan, Xiaobo and Cai, Haifang and Yang, Mingdong and Zhou, Zhuxian and Wang, Guowei},
title = {Ultrasound‐Boosted Liposomal Prodrug Overcomes Age‐Associated Biodistribution Disparity in Pediatric Solid Tumor Therapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202513148}
}
EUVIMED